{"filing":{"accession_number":"0000320121-26-000027","cik":"0000320121","ticker":"TLS","company_name":"TELOS CORP","form":"8-K","filing_date":"2026-05-28","report_date":null,"primary_document":"tls-20260528.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/320121/000032012126000027/tls-20260528.htm"},"events":[{"id":8297,"run_id":7284,"accession_number":"0000320121-26-000027","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"John B. Wood has returned from medical leave and resumed his full duties as President, CEO, and Chairman of the Board effective May 28, 2026. While this involves the resumption of an existing executive role rather than a new appointment, the disclosure centers on Wood's return to active leadership after an interim period where other executives held his responsibilities. The materiality stems from the restoration of the CEO and Chairman roles to their permanent holder, which affects the governance and leadership structure of the company.","company_name":"TELOS CORP","ticker":"TLS","filing_date":"2026-05-28","form":"8-K","submitted_at":null,"items":[{"id":2138,"accession_number":"0000320121-26-000027","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"John B. Wood has returned from medical leave and resumed his full duties as President, CEO, and Chairman of the Board effective May 28, 2026. While this involves the resumption of an existing executive role rather than a new appointment, the disclosure centers on Wood's return to active leadership after an interim period where other executives held his responsibilities. The materiality stems from the restoration of the CEO and Chairman roles to their permanent holder, which affects the governance and leadership structure of the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:10:55.386188+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2138,"accession_number":"0000320121-26-000027","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"John B. Wood has returned from medical leave and resumed his full duties as President, CEO, and Chairman of the Board effective May 28, 2026. While this involves the resumption of an existing executive role rather than a new appointment, the disclosure centers on Wood's return to active leadership after an interim period where other executives held his responsibilities. The materiality stems from the restoration of the CEO and Chairman roles to their permanent holder, which affects the governance and leadership structure of the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:10:55.386188+00:00","company_name":"TELOS CORP","ticker":"TLS","filing_date":"2026-05-28"}]}
